Skip to main content

Advertisement

SpringerLink
Log in

Intraventricular Nicardipine for Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage

  • Original Paper
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction

Delayed ischemic deficit from vasospasm is a leading cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage. Although several treatment modalities have been used to reverse the deleterious effects of vasospasm, alternative therapies are needed, as conventional therapies are often ineffective or contraindicated. Intrathecal nicardipine has been suggested for the prevention of vasospasm. We report our clinical experience with intraventricular nicardipine for refractory vasospasm in eight patients in whom conventional therapies were ineffective, contraindicated, or technically not feasible.

Method

Retrospective case series performed at a tertiary care university hospital.

Results

Eight patients (median Hunt-Hess grade = 2, median Fisher score = 4) with refractory vasospasm received intraventricular nicardipine (4 mg every 12 h) for a total of 5–17 days. One patient died in the intensive care unit. Seven patients had moderate to good outcomes with 6 being discharged to home (median Rankin Score = 2). Intraventricular nicardipine was well tolerated with minimal side effects.

Conclusion

Our preliminary observations suggest that intraventricular nicardipine could be considered as a safe and effective treatment modality to treat vasospasm refractory to conventional management. A randomized, controlled trial to verify the efficacy and safety of intrathecal nicardipine in the prevention and treatment of cerebral vasospasm is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurismal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:2315–28.

    PubMed  CAS  Google Scholar 

  2. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part I: overall management results. J Neurosurg 1990;73:18–36.

    PubMed  CAS  Google Scholar 

  3. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wein) 1994;131:19–25.

    Article  CAS  Google Scholar 

  4. Suzuki M, Mamoru D, Yasunari O, Ogasawara K, Ogawa A. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 2001;24:180–4.

    Article  PubMed  CAS  Google Scholar 

  5. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid hemorrhage. Lancet Neurol 2003;2:614–21.

    Article  PubMed  Google Scholar 

  6. Xi LD, Rhoney DH. Cerebral vasospasm after aneurismal subarachnoid hemorrhage: An overview of pharmacologic management. Pharmacotherapy 2006;26:182–203.

    Article  Google Scholar 

  7. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337–43.

    Article  PubMed  CAS  Google Scholar 

  8. Muizelaar JP, Becker DP. Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage: direct effect on cerebral blood flow. Surg Neurol 1986;25:317–25.

    Article  PubMed  CAS  Google Scholar 

  9. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365–72.

    PubMed  CAS  Google Scholar 

  10. Mori K, Arai H, Nakajima K, Tajima A, Maeda M. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 1995;26:1620–6.

    PubMed  CAS  Google Scholar 

  11. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurologic deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98:978–84.

    PubMed  Google Scholar 

  12. Murai Y, Kominami S, Kobayashi S, Mizunari T, Teramoto A. The long-term effects of transluminal balloon angioplasty for vasospasms after subarachnoid hemorrhage: analyses of cerebral blood flow and reactivity. Surg Neurol 2005;64:122–6.

    Article  PubMed  Google Scholar 

  13. Andaluz N, Tomsick TA, John MT Jr, van Loveren HR, Yeh HS, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol 2002;58:131–8.

    Article  PubMed  Google Scholar 

  14. Milburn JM, Moran CJ, Cross DT III, Diringer MN, Pilgram TK, Dacey RG Jr. Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 1998;88:38–42.

    Article  PubMed  CAS  Google Scholar 

  15. Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–84.

    PubMed  CAS  Google Scholar 

  16. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256–67.

    Article  PubMed  CAS  Google Scholar 

  17. Liu JK, Tenner MS, Gottfried ON, et al. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 2004;100:414–21.

    PubMed  CAS  Google Scholar 

  18. Feng L, Brian-Fred F, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. Am J Neuroradiol 2002;23:1284–90.

    PubMed  Google Scholar 

  19. Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol 2004;25:819–26.

    PubMed  Google Scholar 

  20. Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 2002;50:1006–14.

    Article  PubMed  Google Scholar 

  21. Pathak A, Mathuriya SN, Khandelwal N, Verma K. Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurismal SAH-induced vasospasm. Br J Neurosurg 2003;17:306–10.

    Article  PubMed  CAS  Google Scholar 

  22. Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, William M, Galaria I. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 1999;30:1409–16.

    PubMed  CAS  Google Scholar 

  23. Thomas JE, McGinnis G. Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke 2002;33:486–92.

    Article  PubMed  CAS  Google Scholar 

  24. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005;56:895–902.

    PubMed  Google Scholar 

  25. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002;33:1011–15.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank the members of the Neurosurgery Department and the Neurosciences ICU staff at the Medical University of South Carolina for the care provided to the patients described here.

Author information

Authors and Affiliations

  1. Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA

    Kelly Goodson, Marc Lapointe, Timothy Monroe & Julio A. Chalela

Authors
  1. Kelly Goodson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Lapointe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy Monroe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julio A. Chalela
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julio A. Chalela.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodson, K., Lapointe, M., Monroe, T. et al. Intraventricular Nicardipine for Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage. Neurocrit Care 8, 247–252 (2008). https://doi.org/10.1007/s12028-007-9017-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-007-9017-z

Keywords

Search

Navigation